Skip to content
healthcare.dev

everolimus

NDC 59651-932, everolimus, tablet, from Aurobindo Pharma Limited.

Product NDC
59651-932
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219533
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-932 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EVEROLIMUS.5 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]

Package NDCNDC-11Package
59651-932-605965109326060 TABLET in 1 BOTTLE (59651-932-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/43ef3c29-0e25-4fdd-aea1-06a20af9bbab
  • NADAC price for package 59651093260

    GET /v1/drugs/nadac/59651093260

Use it

Look up 59651-932 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-932 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-932. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.